Neurol. praxi. 2012;13(4):204-209

Inflammatory myopathies

doc.MUDr.Edvard Ehler, CSc.1, doc.MUDr.Josef Zámečník, Ph.D.2
1 Neurologická klinika PKN a.s. a FZS Univerzita Pardubice
2 Ústav patologické anatomie, FN Motol a LF UK Praha

Inflammatory myopathies represent a heterogennic group of acquired myopathies, which have an inflammatory cause. Idiopathic inflammatory

myopathies have the most frequent occurrence and they are differentiated by a course, occurrence of associated diseases,

by treatment effect and by findings in muscle biopsy. Myopathies in systemic diseases, vasculitides, viral, bacterial, fungal and parasitary

infectious diseases have an inflammatory cause too. In the following paper we present overview of basic inflammatory myopathies with

emphasis on the clinical characteristics and muscle biopsy findings.

Keywords: inflammatory myopathies, associated diseases, electromyography, muscle biopsy, differential diagnosis

Published: July 31, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehler E, Zámečník J. Inflammatory myopathies. Neurol. praxi. 2012;13(4):204-209.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Amato AA, Russel JA. Neuromuscular disorders. New York: McGraw Hill Medical 2008.
    2. Ambler Z. Zánětlivé myopatie. Neurol. praxi 2004; 5: 150-154.
    3. Barnes PRJ, Hilton-Jones D. Myopathies in clinical practice. London: Martin Dunitz 2003.
    4. Bednařík J, a kol. Nemoci kosterního svalstva. Praha: Triton 2001.
    5. Bednařík J, Voháňka S, Ehler E, Ambler Z, Piťha J, Vencovský J, Litzman J, Kořístek Z, Suchý M, Pátá M, Kožený P. Standard pro léčbu s autoimunitními nervosvalovými onemocněními intravenózním lidským imunoglobulinem a plazmaferézou. Ces Slov Neurol N 2010; 73/106(5): 570-589.
    6. Cox S, Limaye V, Hill C, Blumbergs P, Roberts Thomson P. Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis 2010; 13: 117-124. Go to original source... Go to PubMed...
    7. Dalakas MC. The future prospects in the classification, diagnosis and therapies of inflammatory myopathies: A view to the future from the, ,bench-to-bedside". J Neurol 2004; 251: 651-657. Go to original source... Go to PubMed...
    8. Dalakas MC, Karpati G. Inflammatory myopathies. In: Karpati G, Hilton-Jones D, Bushby K, Griggs RC (eds). Disorders of voluntary muscles. 8th edition. Cambridge: Cambridge University Press 2010: 427-452. Go to original source...
    9. Dimachkie MM. Idiopathic inflammatory myopathies. J Neuroimmun 2011; 231: 32-42. Go to original source... Go to PubMed...
    10. Distad BJ, Amato AA, Weis MD. Inflammatory myopathies. Curr Treat Options Neurol 2011; 13: 119-130. Go to original source... Go to PubMed...
    11. Khan S, Christopher-Stine L. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features. Rheum Dis Clin N Am 2011; 37: 143-158. Go to original source... Go to PubMed...
    12. Oh SJ. Clinical electromyography. Case studies. Baltimore: Williams&Wilkins 1998.
    13. Pourmand R. Immune-mediated neuromuscular diseases. Basel: Karger 2009. Go to original source...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.